1. Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A.

,
Kingsman, S. M., Carmeliet, P. and Mazarakis, N. D. (2004). VEGF delivery with
retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature
429, 413-417.
2. Bellon, A., Luchino, J., Haigh, K., Rougon, G., Haigh, J., Chauvet, S. and Mann, F.
(2010). VEGFR2 (KDR/Flk1) signaling mediates axon growth in response to semaphorin
3E in the developing brain. Neuron 66, 205-219.
3. Cariboni, A., Davidson, K., Dozio, E., Memi, F., Schwarz, Q., Stossi, F., Parnavelas, J.
G. and Ruhrberg, C. (2011). VEGF signalling controls GnRH neuron survival via NRP1
independently of KDR and blood vessels. Development 138, 3723-3733.
4. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M.,
Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C. et al. (1996). Abnormal blood
vessel development and lethality in embryos lacking a single VEGF allele. Nature 380,
435-439.
5. Carmeliet, P., Ng, Y. S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I.,
Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V. et al. (1999). Impaired myocardial
angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial
growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5, 495-502.
6. Cui, W., Li, W., Han, R., Mak, S., Zhang, H., Hu, S., Rong, J. and Han, Y. (2011). PI3-
K/Akt and ERK pathways activated by VEGF play opposite roles in MPP(+)-induced
neuronal apoptosis. Neurochem. Int. 59, 945-953.
7. Dale-Nagle, E. A., Satriotomo, I. and Mitchell, G. S. (2011). Spinal vascular endothelial
growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase
and Akt signaling. J. Neurosci. 31, 7682-7690.
8. De Bandt,M., BenMahdi,M. H., Ollivier, V., Grossin,M., Dupuis,M., Gaudry,M., et al.
(2003). Blockade of vascular endothelial growth factor receptor I (VEGFRI), but not
VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J.
Immunol. 171, 4853–4859.
9. Eddleston, M. and Mucke, L. (1993). Molecular profile of reactive astrocytesimplications
for their role in neurologic disease. Neuroscience 54, 15-36.
10. Erskine, L., Reijntjes, S., Pratt, T., Denti, L., Schwarz, Q., Vieira, J. M., Alakakone, B.,
Shewan, D. and Ruhrberg, C. (2011). VEGF signaling through neuropilin 1 guides
commissural axon crossing at the optic chiasm. Neuron 70, 951-965.
11. Risau, W. and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91.
12. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-
Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality
induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
13. Ruhrberg, C. (2003). Growing and shaping the vascular tree: multiple roles for VEGF.
BioEssays 25, 1052-1060.
14. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H.,
Betsholtz, C. and Shima, D. T. (2002). Spatially restricted patterning cues provided by
 heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16,
2684-2698.
15. Stalmans, I., Ng, Y. S., Rohan, R., Fruttiger, M., Bouche, A., Yuce, A., Fujisawa, H.,
Hermans, B., Shani, M., Jansen, S. et al. (2002). Arteriolar and venular patterning in
retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327-336.
16. Ng, Y. S., Rohan, R., Sunday, M. E., Demello, D. E. and D’Amore, P. A. (2001).
Differential expression of VEGF isoforms in mouse during development and in the adult.
Dev. Dyn. 220, 112-121.
17. Park, J. E., Keller, G. A. and Ferrara, N. (1993). The vascular endothelial growth factor
(VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and
bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326.
18. Krum, J. M., Mani, N. and Rosenstein, J. M. (2002). Angiogenic and astroglial responses
to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110,
589-604.
19. Mani, N., Khaibullina, A., Krum, J. M. and Rosenstein, J. M. (2005). Astrocyte growth
effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical
explants: Receptor mediation and signal transduction pathways. Exp. Neurol. 192, 394-
406.
20. Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, M.,
Alroy, J., Adelman, L. S., Weinberg, D. H., Ropper, A. H. et al. (2000). Favorable effect
of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 6, 405-413.
21. Silverman, W. F., Krum, J. M., Mani, N. and Rosenstein, J. M. (1999). Vascular, glial
and neuronal effects of vascular endothelial growth factor in mesencephalic explant
cultures. Neuroscience 90, 1529-1541.
22. Sondell, M., Lundborg, G. and Kanje, M. (1999a). Vascular endothelial growth factor has
neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and
Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731-5740.
23. Sondell, M., Lundborg, G. and Kanje, M. (1999b). Vascular endothelial growth factor
stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain
Res. 846, 219-228.
24. Krum, J. M. and Rosenstein, J. M. (1998). VEGF mRNA and its receptor flt-1 are
expressed in reactive astrocytes following neural grafting and tumor cell implantation in
the adult CNS. Exp. Neurol. 154, 57-65.
25. Khaibullina, A. A., Rosenstein, J. M. and Krum, J. M. (2004). Vascular endothelial
growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res.
Mol. Brain Res. 148, 59-68.
26. Rosenstein, J. M., Mani, N., Khaibullina, A. and Krum, J. M. (2003). Neurotrophic
effects of vascular endothelial growth factor on organotypic cortical explants and primary
cortical neurons. J. Neurosci. 23, 11036-11044.
27. Ogunshola, O. O., Antic, A., Donoghue, M. J., Fan, S. Y., Kim, H., Stewart, W. B.,
Madri, J. A. and Ment, L. R. (2002). Paracrine and autocrine functions of neuronal
vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem.
277, 11410-11415.
28. Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van
Dorpe, J., Hellings, P., Gorselink, M., Heymans, S. et al. (2001). Deletion of the hypoxia-
response element in the vascular endothelial growth factor promoter causes motor neuron
degeneration. Nat. Genet. 28, 131-138.
29. Sondell, M., Sundler, F. and Kanje, M. (2000). Vascular endothelial growth factor is a
neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J.
Neurosci. 12, 4243-4254.
30. Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M. P., Appelmans,
S., Oh, H., Van Damme, P., Rutten, B., Man, W. Y., De Mol, M. et al. (2005). Treatment
of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model
of ALS. Nat. Neurosci. 8, 85-92.
31. Haigh, J. J., Morelli, P. I., Gerhardt, H., Haigh, K., Tsien, J., Damert, A., Miquerol, L.,
Muhlner, U., Klein, R., Ferrara, N. et al. (2003). Cortical and retinal defects caused by
dosage-dependent reductions in VEGF-A paracrine signaling. Dev. Biol. 262, 225-241.
32. Islamov, R. R., Chintalgattu, V., Pak, E. S., Katwa, L. C. and Murashov, A. K. (2004).
Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury. NeuroReport
15, 2117-2121.
33. Yang, S. Z., Zhang, L. M., Huang, Y. L. and Sun, F. Y. (2003). Distribution of Flk- 1 and
Flt-1 receptors in neonatal and adult rat brains. Anat. Rec. A Discov. Mol. Cell. Evol.
Biol. 274, 851-856.
34. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. and Shibuya, M. (1998). Flt-1 lacking the
tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.
Proc. Natl. Acad. Sci. USA 95, 9349-9354.
35. Wittko, I. M., Schanzer, A., Kuzmichev, A., Schneider, F. T., Shibuya, M., Raab, S. and
Plate, K. H. (2009). VEGFR-1 regulates adult olfactory bulb neurogenesis and migration
of neural progenitors in the rostral migratory stream in vivo. J. Neurosci. 29, 8704-8714.
36. Zhang, Z. G., Tsang, W., Zhang, L., Powers, C. and Chopp, M. (2001). Upregulation of
neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J. Cereb.
Blood Flow Metab. 21, 541-549.
37. Mukouyama, Y. S., Shin, D., Britsch, S., Taniguchi, M. and Anderson, D. J. (2002).
Sensory nerves determine the pattern of arterial differentiation and blood vessel
branching in the skin. Cell 109, 693-705.
38. Mukouyama, Y. S., Gerber, H. P., Ferrara, N., Gu, C. and Anderson, D. J. (2005).
Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-
mediated positive feedback. Development 132, 941-952. Licht, T., Goshen, I., Avital, A.,
Kreisel, T., Zubedat, S., Eavri, R., Segal, M., Yirmiya, R. and Keshet, E. (2011).
Reversible modulations of neuronal plasticity by VEGF. Proc. Natl. Acad. Sci. USA 108,
5081-5086.
39. James, J. M. and Mukouyama, Y. S. (2011). Neuronal action on the developing blood
vessel pattern. Semin. Cell Dev. Biol. 22, 1019-1027.
40. Lin, J., Li, G., Den, X., Xu, C., Liu, S., Gao, Y., Liu, H., Zhang, J., Li, X. and Liang, S.
(2010). VEGF and its receptor-2 involved in neuropathic pain transmission mediated by
P2X(/) receptor of primary sensory neurons. Brain Res. Bull. 83, 284-291.
41. McCloskey, D. P., Hintz, T. M. and Scharfman, H. E. (2008). Modulation of vascular
endothelial growth factor (VEGF) expression in motor neurons and its
electrophysiological effects. Brain Res. Bull. 76, 36-44.
42. Kim, B. W., Choi, M., Kim, Y. S., Park, H., Lee, H. R., Yun, C. O., Kim, E. J., Choi, J.
S., Kim, S., Rhim, H. et al. (2008). Vascular endothelial growth factor (VEGF) signaling
regulates hippocampal neurons by elevation of intracellular calcium and activation of
calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cell Signal.
20, 714-725.
43. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. and Greenberg, D. A.
(2003). VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal
cerebral ischemia. J. Clin. Invest. 111, 1843-1851.
44. Tovar-y-Romo, L. B., Zepeda, A. and Tapia, R. (2007). Vascular endothelial growth
factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord
neurodegeneration. J. Neuropathol. Exp. Neurol. 66, 913- 922.
45. Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M. P.,
Mitsuda, N. and Tohyama, M. (2001). Vascular endothelial growth factor rescues
hippocampal neurons from glutamate-induced toxicity: signal transduction cascades.
FASEB J. 15, 1218-1220.
46. Bogaert, E., Van Damme, P., Poesen, K., Dhondt, J., Hersmus, N., Kiraly, D.,
Scheveneels, W., Robberecht, W. and Van Den Bosch, L. (2010). VEGF protects motor
neurons against excitotoxicity by upregulation of GluR2. Neurobiol. Aging 31, 2185-
2191.
47. Ma, Y., Liu, W., Wang, Y., Chao, X., Qu, Y., Wang, K. and Fei, Z. (2011). VEGF
protects rat cortical neurons from mechanical trauma injury induced apoptosis via the
MEK/ERK pathway. Brain Res. Bull. 86, 441-446.
48. Bocker-Meffert, S., Rosenstiel, P., Rohl, C., Warneke, N., Held-Feindt, J., Sievers, J. and
Lucius, R. (2002). Erythropoietin and VEGF promote neural outgrowth from retinal
explants in postnatal rats. Invest. Ophthalmol. Vis. Sci. 43, 2021-2026.
49. Svensson, B., Peters, M., Konig, H. G., Poppe, M., Levkau, B., Rothermundt, M., Arolt,
V., Kogel, D. and Prehn, J. H. (2002). Vascular endothelial growth factor protects
cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-
independent mechanism. J. Cereb. Blood Flow Metab. 22, 1170-1175.
50. Jin, K. L., Mao, X. O. and Greenberg, D. A. (2000b). Vascular endothelial growth factor:
direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA 97, 10242-
10247.
51. Raper, J. A. (2000). Semaphorins and their receptors in vertebrates and invertebrates.
Curr. Opin. Neurobiol. 10, 88-94.
52. Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L. and Greenberg, D. A. (2002). Vascular
endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc.
Natl. Acad. Sci. USA 99, 11946-11950.
53. Schanzer, A., Wachs, F. P., Wilhelm, D., Acker, T., Cooper-Kuhn, C., Beck, H., Winkler,
J., Aigner, L., Plate, K. H. and Kuhn, H. G. (2004). Direct stimulation of adult neural
 stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain
Pathol. 14, 237-248.
54. Hashimoto, T., Zhang, X. M., Chen, B. Y. and Yang, X. J. (2006). VEGF activates
divergent intracellular signaling components to regulate retinal progenitor cell
proliferation and neuronal differentiation. Development 133, 2201-2210.
55. Yang, K. and Cepko, C. L. (1996). Flk-1, a receptor for vascular endothelial growth
factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16, 6089-6099.
56. Robinson, G. S., Ju, M., Shih, S. C., Xu, X., McMahon, G., Caldwell, R. B. and Smith, L.
E. (2001). Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal
development. FASEB J. 15, 1215-1217.
57. Lee, C. and Agoston, D. V. (2010). Vascular endothelial growth factor is involved in
mediating increased de novo hippocampal neurogenesis in response to traumatic brain
injury. J. Neurotrauma 27, 541-553.
58. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. and Klagsbrun, M. (1998).
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor
for vascular endothelial growth factor. Cell 92, 735-745.
59. Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J. and Ginty, D. D.
(1997). Neuropilin is a semaphorin III receptor. Cell 90, 753-762.
60. Schwarz, Q. and Ruhrberg, C. (2010). Neuropilin, you gotta let me know: should I stay or
should I go? Cell Adh. Migr. 4, 61-66.
61. Schwarz, Q., Gu, C., Fujisawa, H., Sabelko, K., Gertsenstein, M., Nagy, A., Taniguchi,
M., Kolodkin, A. L., Ginty, D. D., Shima, D. T. et al. (2004). Vascular endothelial
growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct
compartments of the facial nerve. Genes Dev. 18, 2822-2834.
62. Schwarz, Q., Waimey, K. E., Golding, M., Takamatsu, H., Kumanogoh, A., Fujisawa, H.,
Cheng, H. J. and Ruhrberg, C. (2008). Plexin A3 and plexin A4 convey semaphorin
signals during facial nerve development. Dev. Biol. 324, 1-9.
63. Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M. and Carmeliet, P. (2009). Role and
therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 607-648.
64. Kutcher, M. E., Klagsbrun, M. and Mamluk, R. (2004). VEGF is required for the
maintenance of dorsal root ganglia blood vessels but not neurons during development.
FASEB J. 18, 1952-1954.
65. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.
L., Wyns, S., Thijs, V., Andersson, J., van Marion, I. et al. (2003). VEGF is a modifier of
amyotrophic lateral sclerosis in mice and humans and protects motoneurons against
ischemic death. Nat. Genet. 34, 383-394.
66. Vieira, J. M., Schwarz, Q. and Ruhrberg, C. (2007). Selective requirements for NRP1
ligands during neurovascular patterning. Development 134, 1833-1843.
67. Marko, S. B. and Damon, D. H. (2008). VEGF promotes vascular sympathetic
innervation. Am. J. Physiol. Heart Circ. Physiol. 294, H2646-H2652.
68. Long, J. B., Jay, S. M., Segal, S. S. and Madri, J. A. (2009). VEGF-A and
Semaphorin3A: modulators of vascular sympathetic innervation. Dev. Biol. 334, 119-
132.
69. Storkebaum, E., Ruiz de Almodovar, C., Meens, M., Zacchigna, S., Mazzone, M.,
Vanhoutte, G., Vinckier, S., Miskiewicz, K., Poesen, K., Lambrechts, D. et al. (2010).
Impaired autonomic regulation of resistance arteries in mice with low vascular
endothelial growth factor or upon vascular endothelial growth factor trap delivery.
Circulation 122, 273-281.
70. Hulse, R. P., Beazley-Long, N., Ved, N., Bestall, S. M., Riaz, H., Singhal, P., et al. (2015).
Vascular endothelial growth factor-A 165b prevents diabetic neuropathic pain and sensory
neuronal degeneration. Clin. Sci. 129, 741–756. doi: 10.1042/CS20150124
71. Hulse, R. P., Drake, R. A. R., Bates, D. O., and Donaldson, L. F. (2016). The control of
alternative splicing by SRSF1 in myelinated afferents contributes to the development of
neuropathic pain. Neurobiology 96, 186–200. doi: 10.1016/j.nbd.2016.09.009
72. Hulse, R. P. (2017). Role of VEGF-A in chronic pain. Oncotarget 8, 10775–10776. doi:
10.18632/oncotarget.14615
73. Liu, S., Xu, C., Li, G., Liu, H., Xie, J., Tu, G., et al. (2012). Vatalanib decrease the positive
interaction of VEGF receptor-2 and P2X2/3 receptor in chronic constriction injury rats.
Neurochem. Int. 60, 565–572. doi: 10.1016/j.neuint.2012.02.006
74. Matsuoka, A., Maeda, O., Mizutani, T., Nakano, Y., Tsunoda, N., Kikumori, T., et al.
(2016). Bevacizumab exacerbates paclitaxel-induced neuropathy: a retrospective cohort
study. PLoS ONE 11:e0168707. doi: 10.1371/journal.pone.0168707
75. Taiana, M. M., Lombardi, R., Porretta-Serapiglia, C., Ciusani, E., Oggioni, N., Sassone, J.,
et al. (2014). Neutralization of schwann cell-secreted VEGF is protective to in vitro and in
vivo experimental diabetic neuropathy. PLoS ONE 9:e1 08403. doi:
10.1371/journal.pone.0108403
76. Zeng, Y., Han, H., Tang, B., Chen, J., Mao, D., and Xiong, M. (2018). Transplantation of
recombinant vascular endothelial growth factor (VEGF)189-neural stem cells
downregulates transient receptor potential vanilloid 1 (TRPV1) and improves motor
outcome in spinal cord injury. Med. Sci. Monit. 24, 1089–1096.